Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 19, 2023 03:00 ET | Source: Olink Proteomics AB

Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.

Uppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research. ...
August 09, 2021 11:58 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering

MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
August 04, 2020 08:30 ET | Source: RenovaCare, Inc.

RenovaCare Appoints Dr. Lydia M. Evans to Its Board of Directors and Increases Board Membership

ROSELAND, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
March 30, 2020 08:32 ET | Source: RenovaCare, Inc.

Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London

ROSELAND, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
June 01, 2017 16:24 ET | Source: AntiCancer PDOX, Inc.

AntiCancer PDOX Reaches Series A Financing Target, Appoints Board

CHICAGO, June 01, 2017 (GLOBE NEWSWIRE) -- ASCO 2017 -- AntiCancer PDOX, Inc. announced today that it has reached its original Series A financing target and appointed its Board of...
August 16, 2016 11:38 ET | Source: PreveCeutical Medical Inc

PreveCeutical Announces the Appointment of Dr. Makarand Jawadekar as Chief Science Officer; Announces Accelerated Pre-Clinical Program for Nature Identical Peptide, Similar to the Active Found in Caribbean Blue Scorpion Venom

VANCOUVER, British Columbia, Aug. 16, 2016 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. ("PreveCeutical," or the "Company"), a health and wellness company focused on utilizing nature and science...